Impact of Pretreatment With Antidepressants on the Efficacy of Duloxetine in Terms of Mood Symptoms and Functioning | Zendy

Bruno R. Barros | Zendy; Alexander Schacht | Zendy; Michael Happich | Zendy; Foula Televantou | Zendy; Lovisa Berggren | Zendy; Daniel Walker | Zendy; Héctor Dueñas | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Impact of Pretreatment With Antidepressants on the Efficacy of Duloxetine in Terms of Mood Symptoms and Functioning

Author(s) -

Bruno R. Barros,

Alexander Schacht,

Michael Happich,

Foula Televantou,

Lovisa Berggren,

Daniel Walker,

Héctor Dueñas

Publication year - 2014

Publication title -

the primary care companion for cns disorders

Language(s) - English

Resource type - Journals

eISSN - 2155-7772

pISSN - 2155-7780

DOI - 10.4088/pcc.14m01661

Subject(s) - duloxetine , placebo , rating scale , antidepressant , major depressive disorder , montgomery–åsberg depression rating scale , medicine , post hoc analysis , psychology , depression (economics) , psychiatry , escitalopram , duloxetine hydrochloride , hamilton anxiety rating scale , mood , anxiety , developmental psychology , alternative medicine , pathology , economics , macroeconomics

This post hoc analysis aimed to determine whether patients with major depressive disorder (MDD) in duloxetine trials who were antidepressant naive or who were previously exposed to antidepressants exhibited differences in efficacy and functioning.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research